ECCA Nordic announces the launch of a new strategic partnership with BioPortUSA. The goal of this new relationship is to help facilitate cross border trade between life science companies based in Nordics and the United States.
”Having access to a firm like BioPortUSA will help simplify the market entry process for Nordic based companies who need to navigate the changing FDA regulatory environment, as well as legal, tax, insurance and commercialization requirements imposed by the US market.” says Minna Storm
The collaboration between BioPortUSA and ECCA Nordic should provide a great platform for business growth and success between these two regions of the world.